✦ LIBER ✦

The role of mTOR inhibitors in the treatment of hepatocellular carcinoma

✍ Scribed by Huang, Yi-Hsiang; Lin, Han-Chieh

Book ID: 120983936
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 87 KB
Volume: 33
Category: Article
ISSN: 0106-9543
DOI: 10.1111/liv.12213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

mTOR Inhibitor for the Treatment of Hepa

mTOR Inhibitor for the Treatment of Hepatocellular Carcinoma

✍ Kudo, Masatoshi 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 314 KB

The role of mTOR inhibitors for treatmen

The role of mTOR inhibitors for treatment of sarcomas

✍ Monica M. Mita; Anthony W. Tolcher 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 273 KB

mTOR Inhibitors and its Role in the Trea

mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma

✍ Shaun A. Nguyen; David Walker; M. Boyd Gillespie; J. Silvio Gutkind; Terry A. Da 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 148 KB

The potential role of mTOR inhibitors in

The potential role of mTOR inhibitors in the treatment of endocrine tumors

✍ Grozinsky-Glasberg, S.; Shimon, I. 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 105 KB

mTOR inhibitors in the treatment of canc

mTOR inhibitors in the treatment of cancer

✍ Fasolo, Angelica; Sessa, Cristiana 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 605 KB

Role of liver transplantation in the tre

Role of liver transplantation in the treatment of hepatocellular carcinoma

✍ Shunzaburo Iwatsuki; Thomas E. Starzl 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

## Abstract The results obtained by liver transplantation (TX) (n = 105) for hepatocellular carcinoma (HCC) were compared with those achieved by hepatic resection (HX) (n = 76). Overall 1‐ to 5‐year survival rates after TX were 66%, 49%, 39%, 36%, and 36%, and those after HX were 71%, 55%, 47%, 37%